Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:PC O-45:13)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST004300 AN007152 Two-dimensional liquid chromatography-mass spectrometry (2DLC-MS) platform to conduct an in-depth lipidomic analysis of liver and brain tissues from fat-1 transgenic mice exposed to ethanol. Brain Mouse Liver disease University of Louisville LC-MS
ST004300 AN007152 Two-dimensional liquid chromatography-mass spectrometry (2DLC-MS) platform to conduct an in-depth lipidomic analysis of liver and brain tissues from fat-1 transgenic mice exposed to ethanol. Liver Mouse Liver disease University of Louisville LC-MS
ST004300 AN007154 Two-dimensional liquid chromatography-mass spectrometry (2DLC-MS) platform to conduct an in-depth lipidomic analysis of liver and brain tissues from fat-1 transgenic mice exposed to ethanol. Brain Mouse Liver disease University of Louisville LC-MS
ST004300 AN007154 Two-dimensional liquid chromatography-mass spectrometry (2DLC-MS) platform to conduct an in-depth lipidomic analysis of liver and brain tissues from fat-1 transgenic mice exposed to ethanol. Liver Mouse Liver disease University of Louisville LC-MS
ST003108 AN005089 Complete absence of GLUT1 does not impair human terminal erythroid differentiation Cultured cells Human GLUT1 Deficiency Syndrome University of Colorado LC-MS
  logo